Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 5 Sponsors

Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug.

Chamber: Senate
Introduced: Mar 18, 2026
Last action: Jun 1, 2026 — SUBSTITUTED BY A1428
Session: 2025-2026
Momentum: 28 · Low

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 5%, measured from NY's completed sessions
Momentum -5 28/100 from the pace of recorded action
Time since last action -19 134 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.